Ligand Pharmaceuticals financials at a glance
| Year | Year | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$69.33M | $80.77M | $10.22M | $3.98M | $12.89M | $27.32M | $38.94M | $23.54M | $30.04M | $31.39M | $48.97M | $64.54M | $71.91M | $108.97M | $141.10M | $251.45M | $120.28M | $186.42M | $277.13M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
61.70% | 77.39% | 100.00% | 50.52% | 100.00% | 100.00% | 45.57% | 6.25% | 49.40% | 54.15% | 69.36% | 70.74% | 76.62% | 75.41% | 77.14% | 86.40% | 44.09% | 51.82% | 52.66% | 0.00% | 0.00% |
| OI | Operating Income |
|
$-85.80M | $-46.72M | $-43.63M | $-81.48M | $-54.74M | $-27.24M | $-16.14M | $-11.36M | $0.25M | $1.22M | $15.98M | $20.71M | $27.33M | $43.89M | $68.08M | $163.73M | $-5.72M | $29.43M | $41.30M | $0.00M | $0.00M |
| OM | Operating Margin |
|
-123.76% | -57.85% | 0.00% | 0.00% | 0.00% | -99.73% | -41.45% | -48.25% | 0.85% | 3.87% | 32.64% | 32.09% | 38.00% | 40.27% | 48.25% | 65.11% | -4.76% | 15.79% | 14.90% | 0.00% | 0.00% |
| NI | Net Income |
|
$-96.47M | $-45.14M | $-36.40M | $-31.74M | $281.69M | $-98.11M | $-1.95M | $-10.37M | $9.72M | $-0.53M | $11.42M | $12.02M | $229.82M | $-1.64M | $12.56M | $143.32M | $629.30M | $-2.99M | $57.14M | $0.00M | $0.00M |
| EPS | Earnings Per Share |
|
$-3.66 | $-2.94 | $6.00 | $17.22 | $-1.62 | $0.30 | $0.18 | $0.63 | $-0.12 | $0.90 | $1.52 | $3.37 | $3.33 | $3.26 | $7.15 | $3.09 | $4.55 | $6.42 | |||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
12.2m | 12.32m | 12.34m | 16.75m | 15.88m | 18.83m | 19.56m | 19.51m | 19.56m | 20.16m | 20.47m | 19.58m | 19.95m | 20.91m | 21.15m | 20.77m | 16.82m | 16.08m | 16.77m | 16.86m | 0m |
| OCF | Operating Cash Flow |
|
$0.31M | $5.75M | $8.37M | $-138.52M | $-97.73M | $-20.63M | $-33.80M | $-27.07M | $-1.17M | $0.16M | $20.69M | $20.57M | $41.73M | $60.73M | $88.57M | $194.06M | $-29.34M | $54.59M | $78.80M | $0.00M | $0.00M |
| CS | Cap Spending |
|
$-2.78M | $-3.60M | $-2.60M | $-1.78M | $-0.44M | $-0.50M | $-0.52M | $-0.07M | $-0.08M | $-0.60M | $-0.38M | $-0.01M | $-0.09M | $-1.85M | $-2.16M | $-0.89M | $-2.55M | $-4.46M | $-8.76M | $-4.46M | $0.00M |
| FCF | Free Cash Flow |
|
$-2.47M | $2.15M | $5.77M | $-140.30M | $-98.17M | $-21.13M | $-34.32M | $-27.14M | $-1.25M | $-0.44M | $20.31M | $20.56M | $41.64M | $58.88M | $86.41M | $193.17M | $-31.89M | $50.13M | $70.04M | $0.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.56 | $0.18 | $0.47 | $-10.44 | $-6.00 | $-1.33 | $-1.82 | $-1.45 | $-0.06 | $-0.02 | $0.82 | $0.96 | $1.90 | $1.98 | $4.44 | $8.66 | $41.11 | $3.18 | $4.24 | $0.00 | $0.00 |